Literature DB >> 21983314

Bromocriptine for diabetes mellitus type II.

Guy Valiquette1.   

Abstract

A quick-release formulation of bromocriptine is the latest drug approved by the US Food and Drug Administration for the treatment of type 2 diabetes mellitus. Most interestingly, the development of this drug stems from studies of hibernation in rodents. This article will review the physiology that led to the development of this new drug, as well as its indications, clinical use, benefits, and contraindications.

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21983314     DOI： 10.1097/CRD.0b013e318229d2d2

Source DB:  PubMed          Journal:  Cardiol Rev        ISSN： 1061-5377            Impact factor:   2.644


  7 in total

Review 1.  16-kDa prolactin and bromocriptine in postpartum cardiomyopathy.

Authors:  Denise Hilfiker-Kleiner; Ingrid Struman; Melanie Hoch; Edith Podewski; Karen Sliwa
Journal:  Curr Heart Fail Rep       Date:  2012-09

2.  Dopamine increases HIV entry into macrophages by increasing calcium release via an alternative signaling pathway.

Authors:  E A Nickoloff-Bybel; P Mackie; K Runner; S M Matt; H Khoshbouei; P J Gaskill
Journal:  Brain Behav Immun       Date:  2019-08-27       Impact factor: 7.217

3.  Selectivity, cell permeability and oral availability studies of novel bromophenol derivative HPN as protein tyrosine phosphatase 1B inhibitor.

Authors:  Jiao Luo; Qi Xu; Bo Jiang; Renshuai Zhang; Xiaoling Jia; Xiangqian Li; Lijun Wang; Chuanlong Guo; Ning Wu; Dayong Shi
Journal:  Br J Pharmacol       Date:  2017-12-08       Impact factor: 8.739

4.  Intrinsic and Antipsychotic Drug-Induced Metabolic Dysfunction in Schizophrenia.

Authors:  Zachary Freyberg; Despoina Aslanoglou; Ripal Shah; Jacob S Ballon
Journal:  Front Neurosci       Date:  2017-07-28       Impact factor: 4.677

5.  Dual pancreatic adrenergic and dopaminergic signaling as a therapeutic target of bromocriptine.

Authors:  Despoina Aslanoglou; Suzanne Bertera; Laura Friggeri; Marta Sánchez-Soto; Jeongkyung Lee; Xiangning Xue; Ryan W Logan; J Robert Lane; Vijay K Yechoor; Peter J McCormick; Jens Meiler; R Benjamin Free; David R Sibley; Rita Bottino; Zachary Freyberg
Journal:  iScience       Date:  2022-07-19

Review 6.  Metabolic effects of prolactin and the role of dopamine agonists: A review.

Authors:  Polly Kirsch; Jessica Kunadia; Shruti Shah; Nidhi Agrawal
Journal:  Front Endocrinol (Lausanne)       Date:  2022-09-30       Impact factor: 6.055

7.  Development of a Rapid Insulin Assay by Homogenous Time-Resolved Fluorescence.

Authors:  Zachary J Farino; Travis J Morgenstern; Julie Vallaghe; Nathalie Gregor; Prashant Donthamsetti; Paul E Harris; Nicolas Pierre; Robin Freyberg; Fabienne Charrier-Savournin; Jonathan A Javitch; Zachary Freyberg
Journal:  PLoS One       Date:  2016-02-05       Impact factor: 3.240
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.